Fetching results...
0 items found

A0336: Prognostic value of fat loss in patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint inhibition

Dr. J. (Jihwan) Lee
Lee J.1, Lee S.M.1, Lee J.H.2, Hwang S.3, Jee B.4, Kim J.5, Chung J.H.6, Song W.6, Sung H.H.6, Jeon H.G.6, Jeong B.C.6, Seo S.I.6, Jeon S.S.6, Lee H.M.6, Park S.H.7, Kwon G.Y.8, Kang M.1
1Samsung Medical Center, Dept. of Urology, Seoul, South Korea, 2Samsung Medical Center, Dept. of Radiology, Seoul, South Korea, 3Samsung Medical Center, Dept. of Pathology, Seoul, South Korea, 4Sungkyunkwan University School of Medicine, Dept. of Urology, Seoul, South Korea, 5Samsung Medical Center, Dept. of Radiology and Center for Imaging Sciences, Seoul, South Korea, 6Sungkyunkwan University of Medicine, Dept. of Urology, Seoul, South Korea, 7Sungkyunkwan University of Medicine, Dept. of Medical Oncology, Seoul, South Korea, 8Samsung Medical Center, Dept. of Pathology and Translational Genomics, Seoul, South Korea
38th Annual EAU Congress
Date – Time - Location
11 March 2023, 17:15 - 18:45, Pink Area, Coral 6
Abstract Session 19 - Update on mRCC - surgery and medical therapy. Miscellaneous on localised RCC
Renal Tumour, Metastatic - Follow up, Clinical / Prognosis
  • © 2023 European Association of Urology
  • Disclaimer